PFE - Pfizer Insider Trading: Former Employee Found Guilty Of Trading On Successful COVID-19 Paxlovid Trial News | Benzinga
Amit Dagar, a former senior statistical program lead at Pfizer Inc (NYSE:PFE), has been found guilty of securities fraud by a federal jury in Manhattan.
In October, Pfizer slashed its full-year earnings and revenue guidance, citing decreasing demand for its COVID-19 products.
The conviction comes after Dagar was accused of engaging in insider trading by purchasing stock options just before Pfizer announced the clinical trial results for the COVID antiviral drug Paxlovid in November 2021.
Dagar was convicted on one count of securities fraud, with prosecutors asserting that he not only ...